By blocking the PI3K/AKT pathway, which reduces NF-κB expression, Cur increases the sensitivity of cancer cells to treatment (Mortezaee et al., 2019a; Villegas et al., 2021; Abadi et al., 2022). This evidence concerns the gene NFKB1 and cancer.